Front Row Advisors LLC Takeda Pharmaceutical CO LTD Transaction History
Front Row Advisors LLC
- $276 Million
- Q2 2025
A detailed history of Front Row Advisors LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Front Row Advisors LLC holds 86 shares of TAK stock, worth $1,193. This represents 0.0% of its overall portfolio holdings.
Number of Shares
86
Previous 145
40.69%
Holding current value
$1,193
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding TAK
# of Institutions
368Shares Held
73.1MCall Options Held
1.68MPut Options Held
157K-
Capital Research Global Investors Los Angeles, CA13.3MShares$185 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.62MShares$106 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.5MShares$62.5 Million0.01% of portfolio
-
Ubs Group Ag4.02MShares$55.9 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.71MShares$51.5 Million0.54% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $43.2B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...